Status:
COMPLETED
Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19
Lead Sponsor:
Ain Shams University
Collaborating Sponsors:
Misr International University
Conditions:
Covid19
Corona Virus Infection
Eligibility:
All Genders
18-65 years
Brief Summary
Since the end of 2019, Egypt and the whole world have been suffering from the Coronavirus Disease 2019 (COVID-19) pandemic, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS...
Eligibility Criteria
Inclusion
- Age 18 to 65 years..
- COVID-19 hospitalized patients with pneumonia proved by chest X-ray or CT scan.
- Confirmed infection with COVID-19 virus using RT-PCR or strongly suspected to be infected with pending confirmation studies.
- Prothrombin time/international normalized ratio (INR)\<1.5; activated partial thromboplastin time (aPTT)/ratio\<1.5, and platelet count greater than 100,000/mm3.
Exclusion
- Age greater than 85 years-old
- Creatinine clearance (CrCl)\<10ml/min.
- Severe circulatory shock with a dose of norepinephrine higher than 1.0 μg/kg/min.
- Pregnant women.
- Recent major surgery or severe trauma in the last 3 weeks or recent hemorrhagic stroke in the last 3 months.
- Active bleeding, blood dyscrasia such as hemophilia and Von Willebrand factor deficiency.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04736901
Start Date
December 1 2020
End Date
December 1 2021
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Teachers Hospital
Cairo, Please Select, Egypt, 11314